PML and acute promyelocytic leukemia: Arsenic trioxide (As2O3) is a therapeutic drug used for the treatment of acute promyelocytic leukemia (APL) by promoting degradation of the PML–retinoic acid receptor-α (PML-RAR) oncogene (48).